Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone

Free Abstracts

  Rheumatoid Arthritis

  Free Subscription


5 Arthritis Res Ther
1 Clin Rheumatol
3 J Rheumatol
2 PLoS One
1 Rheumatol Int

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    Arthritis Res Ther

  1. JIN Y, Desai RJ, Liu J, Choi NK, et al
    Factors associated with initial or subsequent choice of biologic disease-modifying antirheumatic drugs for treatment of rheumatoid arthritis.
    Arthritis Res Ther. 2017;19:159.
    PubMed     Text format     Abstract available

  2. OH BR, Suh DH, Bae D, Ha N, et al
    Therapeutic effect of a novel histone deacetylase 6 inhibitor, CKD-L, on collagen-induced arthritis in vivo and regulatory T cells in rheumatoid arthritis in vitro.
    Arthritis Res Ther. 2017;19:154.
    PubMed     Text format     Abstract available

  3. CASTANEDA S, Llorente I, Garcia-Vicuna R, Gonzalez-Alvaro I, et al
    Anti-citrullinated protein antibodies and bone loss in patients with early arthritis: comment on the article "Anti-citrullinated protein antibodies and high levels of rheumatoid factor are associated with systemic bone loss in patients with early untr
    Arthritis Res Ther. 2017;19:152.
    PubMed     Text format    

  4. SCHOELS M, Alasti F, Smolen JS, Aletaha D, et al
    Evaluation of newly proposed remission cut-points for disease activity score in 28 joints (DAS28) in rheumatoid arthritis patients upon IL-6 pathway inhibition.
    Arthritis Res Ther. 2017;19:155.
    PubMed     Text format     Abstract available

  5. BONDT A, Nicolardi S, Jansen BC, Kuijper TM, et al
    IgA N- and O-glycosylation profiling reveals no association with the pregnancy-related improvement in rheumatoid arthritis.
    Arthritis Res Ther. 2017;19:160.
    PubMed     Text format     Abstract available

    Clin Rheumatol

  6. BOLETO G, Drame M, Lambrecht I, Eschard JP, et al
    Disease-modifying anti-rheumatic drug effect of denosumab on radiographic progression in rheumatoid arthritis: a systematic review of the literature.
    Clin Rheumatol. 2017 Jul 1. doi: 10.1007/s10067-017-3722.
    PubMed     Text format     Abstract available

    J Rheumatol

  7. BERENDSEN MLT, van Maaren MC, Arts EEA, den Broeder AA, et al
    Anticyclic Citrullinated Peptide Antibodies and Rheumatoid Factor as Risk Factors for 10-year Cardiovascular Morbidity in Patients with Rheumatoid Arthritis: A Large Inception Cohort Study.
    J Rheumatol. 2017 Jul 1. pii: jrheum.160670. doi: 10.3899/jrheum.160670.
    PubMed     Text format     Abstract available

  8. TWIGG S, Hensor EMA, Emery P, Tennant A, et al
    Patient-reported Outcomes as Predictors of Change in Disease Activity and Disability in Early Rheumatoid Arthritis: Results from the Yorkshire Early Arthritis Register.
    J Rheumatol. 2017 Jul 1. pii: jrheum.161214. doi: 10.3899/jrheum.161214.
    PubMed     Text format     Abstract available

  9. KUIJPER TM, Buisman LR, Hazes JM, Weel AE, et al
    Cost-effectiveness of Biological Disease-modifying Antirheumatic Drugs for the Treatment of Rheumatoid Arthritis: Implications for Clinical Practice.
    J Rheumatol. 2017;44:965-967.
    PubMed     Text format    

    PLoS One

  10. ZOU K, Xiao FK, Li HY, Zhou Q, et al
    Risk of cardiovascular disease in Chinese patients with rheumatoid arthritis: A cross-sectional study based on hospital medical records in 10 years.
    PLoS One. 2017;12:e0180376.
    PubMed     Text format     Abstract available

  11. VIDAL-BRALO L, Perez-Pampin E, Regueiro C, Montes A, et al
    Anti-carbamylated protein autoantibodies associated with mortality in Spanish rheumatoid arthritis patients.
    PLoS One. 2017;12:e0180144.
    PubMed     Text format     Abstract available

    Rheumatol Int

  12. GALARZA-DELGADO DA, Azpiri-Lopez JR, Colunga-Pedraza IJ, Cardenas-de la Garza JA, et al
    Prevalence of comorbidities in Mexican mestizo patients with rheumatoid arthritis.
    Rheumatol Int. 2017 Jul 5. doi: 10.1007/s00296-017-3769.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Rheumatoid Arthritis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.